£128.99

TUBERCULOSIS MULTIDRUG RESI.: Epidemiology, Diagnosis, Resistance Mechanisms, Treatment Strategies & Novel Drugs (Allergies and Infectious Diseases)

Illnesses & Conditions

Price data last checked 26 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£129 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 65 days • 1 price levels

Days at Price

Price Analysis

Most common price: £129 (65 days, 100.0%)

Price range: £129 - £129

Price levels: 1 different prices over 65 days

Description

Tuberculosis (TB), causing nine million active disease cases and 1.5 million deaths every year, is a formidable public health challenge, particularly in poor and developing countries around the world. Major reasons for global burden of TB include association of active disease with human immunodeficiency virus (HIV) coinfection or other underlying immunosuppressive conditions such as diabetes and increasing incidence of drug-resistant, multidrug-resistant (MDR) (resistant at least to rifampicin and isoniazid) and extensively drug-resistant (XDR) (additionally resistant to a fluoroquinolone plus kanamycin/amikacin/capreomycin) strains of M. tuberculosis. While treatment of drug-susceptible TB is effective in >95 percent of disease cases, supervised therapy for >6 months is challenging. Inadequate/inappropriate therapy due to inability of poor patients to pay for drugs and non-adherence to treatment (regimen and duration) often results in much lower cure rates and evolution of drug-resistant strains of M. tuberculosis due to mutations occurring at a predictable rate in genes encoding drug targets. Sequential accumulation of mutations results in evolution of MDR and XDR strains of M. tuberculosis. Today, drug-resistant TB and MDR-TB have become prevalent in many parts of the world and XDR-TB strains are emerging rapidly. While MDR-TB is difficult to treat, XDR-TB is untreatable in most developing countries.

Product Specifications

Format: hardcover
ASIN: 1628083093
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions
Domain: Amazon UK
Release Date: 01 August 2013
Listed Since: 06 June 2013

Barcode

No barcode data available

TUBERCULOSIS MULTIDRUG RESI.: Epidemiology, Diagnosis, Resistance Mechanisms, Treatment Strategies & Novel Drugs (Allergies and Infectious Diseases)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Tuberculosis: 215 (Current Topics in Microbiology and Immunology, 215)

Tuberculosis and Nontuberculosis Mycobacterial Infections

Tuberculosis Host-Pathogen Interactions

Mycobacterium Tuberculosis Protocols: 54 (Methods in Molecular Medicine, 54)

Mycobacteria: Molecular Biology and Virulence

Antimicrobial Resistance: Control Mechanism, Regulation and Clinical Implications

Antimicrobial Resistance in Developing Countries

Mycobacteria: I Basic Aspects

Structural and Functional Dynamics of Nontuberculous Mycobacterium Proteins: Insights into Pathogenic Mechanisms

Natural Antioxidants: An Approach Towards Tuberculosis Management: Green Tea Polyphenol (EGCG) as Potential Adjunct in Combating Mycobacterium tuberculosis Pathogenesis

Isolation and Molecular Characterization of Mycobacterium Bovis: Isolation and Molecular Characterization of M.Bovis from Cattle Slaughtered at Hawassa University and Municipal Abattoir

Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria

A Brief Social History of Tuberculosis: Key Challenges to Global Health (Routledge Focus)

Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance

Microbial Resistance to Drugs: 91 (Handbook of Experimental Pharmacology, 91)

Antimicrobials and Antimicrobial Resistance in the Environment

Pulmonary Infection: 857 (Advances in Experimental Medicine and Biology, 857)

Drug susceptibilities and mechanisms in Salmonella typhimurium: Drug susceptibilities and mechanisms of drug resistance among Salmonella enterica serovar typhimurium

The New Paradigm of Immunity to Tuberculosis: 783 (Advances in Experimental Medicine and Biology, 783)

Combating Pulmonary Tuberculosis: The Ginger Way: Ginger (Gingiber officinale) Cures Pulmonary Tuberculosis and related disorders of Acute Phase Protein along with Anemia

Environmental Antimicrobial Resistance: A Complete Handbook

Advances in Biosensor Technology for Mycobacterium Tuberculosis Detection

Antimalarial Drugs I: Biological Background, Experimental Methods, and Drug Resistance: 68 / 1 (Handbook of Experimental Pharmacology, 68 / 1)

Antimicrobial Resistance: A Crisis in Health Care: 390 (Advances in Experimental Medicine and Biology, 390)